LiDCO says that it is on track to meet 2019-20 expectations.
The patient monitoring equipment developer increased product sales by 10% to £3.33m in the first half, thanks to strong growth in the US and rest of the world. There was a 9% fall in the UK.
High usage programme licence revenue more than doubled and annualised revenues are £2.1m. Total revenues were 4% ahead at £3.5m, because of the loss of a distributorship for a third party product.
Net cash was £1.2m at the end of July 2019.
© 2020 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.